UnknownPhase 2

Intrathecal Stem Cells for Cerebral Palsy Phase II

Mexico60 participantsStarted 2013-09

Plain-language summary

The purpose of this study is to determine whether the infusion of intrathecal autologous bone marrow total nucleated cells would improve the neurologic evolution of pediatric patients with quadriparetic cerebral palsy.

Who can participate

Age range7 Years – 9 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with quadriplegic cerebral palsy, with an age from 7 to 9 years of age, regardless the age at the time of injury, time post-injury, or previously received therapies, different from ours Exclusion Criteria: * Patients with neurodegenerative or autoimmune diseases * Patients with active infection in any organ or tissue at the time of entering the study, the onset of stimulation with G-CSF or at the procedure * Patients who do not sign the informed consent form

What they're measuring

Number of participants who show progress in GMFCS scale after autologous bonemarrow TNC intrathecal infusion.

Timeframe: six months

Trial details

NCT IDNCT02231242

SponsorHospital Universitario Dr. Jose E. Gonzalez

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

Contact for this trial

Consuelo Mancias-Guerra, MD

+52 81 83 48 61 36 consuelomanciasg@gmail.com

View on ClinicalTrials.gov More Cerebral Palsy trials